Add the GLP-1 Microdosing Protocol for only $97
The GLP-1 Microdosing Protocol utilizing the RESET™ Method gives you the medication strategy: candidate evaluation, biomarker review, low-dose titration guidance, side effect management, tapering, and long-term maintenance planning to support a weight loss or longevity program in your practice.
Because GLP-1 access is everywhere.
GLP-1 strategy is not.
What's Inside:
✦ The RESET™ Clinical Framework
A structured methodology for assessing GLP-1 microdosing candidates through root-cause readiness, systemic support, protocol evolution, and long-term transition planning.
✦ Lab + Biomarker Assessment Guide
A metabolic and inflammatory assessment framework that helps you evaluate glucose, insulin, HOMA-IR, hs-CRP, homocysteine, ferritin, omega-3 status, hormone patterns, thyroid function, cortisol, gut health, and liver markers before jumping into treatment.
✦ GLP-1 Microdosing Schedule
Dosing and titration guidance for semaglutide and tirzepatide, designed to support a more measured approach than aggressive weight-loss models.
✦ Clinical Decision Tree + Risk Stratification
A practical guide for determining who may be low, moderate, or higher risk based on metabolic markers, inflammation, hormone patterns, and gut/detox considerations.
✦ Hormone + Inflammation Optimization Support
Guidance for addressing the factors that can influence metabolic response, including thyroid, adrenal, sex hormone, nutrient, gut, inflammation, and mitochondrial support.
✦ Supplement + Lifestyle Protocols
Clinical support for protein intake, strength training, Zone 2 cardio, metabolic flexibility, gut support, mitochondrial health, detoxification, inflammation reduction, and long-term maintenance.
✦ SOP + SOAP Note Templates
Implementation support so your team has a clearer process for patient assessment, treatment initiation, monitoring, documentation, and follow-up.
✦ Side Effect + Tapering Guidance
Patient-facing and provider-facing guidance for managing common side effects, monitoring progress, adjusting dose, and transitioning off therapy when clinically appropriate.
